BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12389565)

  • 1. Haemolytic-anaemia relapses after immunisation and pertussis.
    Gündüz Gedikoğlu A; Cantez T
    Lancet; 1967 Oct; 2(7521):894-5. PubMed ID: 12389565
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEMOLYTIC-UREMIC SYNDROMES FOLLOWING TRIPLE VACCINATION (DIPHTHERIA-PERTUSSIS-TETANUS)].
    GUERRA AU; LORENZOYDEIBARRETA J; TEMESIO N
    Arch Pediatr Urug; 1965 Jan; 36():26-38. PubMed ID: 14294753
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.
    Heijbel H; Ciofi degli Atti M; Harzer E; Liese J; Preziosi MP; Rasmussen F; Schmitt HJ; Storsaeter J; Taranger J; Uberall M; Tozzi AE
    Dev Biol Stand; 1997; 89():101-3. PubMed ID: 9272338
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
    BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Castleman's disease with autoimmune haemolytic anaemia, subfertility and meningomyelocele.
    Weerasuriya N; Ranasinghe LM; Wijesiriwardene IS; Fernando DJ
    Ceylon Med J; 2001 Dec; 46(4):154-5. PubMed ID: 12164037
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of acellular pertussis vaccine: follow-up studies.
    Chen RT
    Dev Biol Stand; 1997; 89():373-5. PubMed ID: 9272374
    [No Abstract]   [Full Text] [Related]  

  • 8. Pertussis in a previously immunized child with human immunodeficiency virus infection.
    Adamson PC; Wu TC; Meade BD; Rubin M; Manclark CR; Pizzo PA
    J Pediatr; 1989 Oct; 115(4):589-92. PubMed ID: 2795352
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
    Sato H; Sato Y
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the clinical development of a diphtheria-tetanus--acellular pertussis vaccine.
    Bogaerts H; Capiau C; Hauser P; Mareschal JC; Mélot V; Simons D
    J Infect Dis; 1996 Nov; 174 Suppl 3():S276-80. PubMed ID: 8896529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis).
    IPSEN J; BOWEN HE
    Am J Public Health Nations Health; 1955 Mar; 45(3):312-8. PubMed ID: 14350122
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of local reactions to two formulations of DPT vaccine.
    Freeman T; Cuff W; Duclos P; Stewart MA; Morris B; Cloutier-Fisher D
    Can Commun Dis Rep; 1994 Aug; 20(15):129-32. PubMed ID: 7920365
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined diphtheria-tetanus-pertussis vaccine. II. Postvaccinal reactions and immunological response in vaccinated children].
    CALALB G
    Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():667-76. PubMed ID: 13875655
    [No Abstract]   [Full Text] [Related]  

  • 15. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children.
    Miller D; Wadsworth J; Diamond J; Ross E
    Dev Biol Stand; 1985; 61():389-94. PubMed ID: 3879684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why pertussis immunisation?
    Tribe P
    Aust Fam Physician; 1989 Aug; 18(8):985-90. PubMed ID: 2673176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of human antipertussis vaccines of domestic production. III. Epidemiological evaluation of the pertussis component of diphtheria-tetanus-pertussis vaccines].
    ADONAJLO A; PIATKOWSKI J; DZIKOWSKA J; MAGDZIARZ H; GILEWSKA A
    Przegl Epidemiol; 1962; 16():423-30. PubMed ID: 14040955
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune haemolytic anaemia as an initial presentation of primary Sjögren syndrome.
    Subbarayudu B; Sharma MS; Sreemannarayana P
    Intern Med J; 2014 Dec; 44(12a):1259-61. PubMed ID: 25442764
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicolau's syndrome in a newborn caused by triple DTP (diphtheria-tetanus-pertussis) vaccination.
    Erkek E; Tuncez F; Sanli C; Duman D; Kurtipek GS; Bagci Y; Ayaslioglu E
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S241-2. PubMed ID: 16631955
    [No Abstract]   [Full Text] [Related]  

  • 20. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.
    Rennels MB; Deloria MA; Pichichero ME; Losonsky GA; Englund JA; Meade BD; Anderson EL; Steinhoff MC; Edwards KM
    Pediatrics; 2000 Jan; 105(1):e12. PubMed ID: 10617749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.